Reproduced with kind permission from the Department of Work and Pensions. Found online at M http://www.dwp.gov.uk d i s e a s e s 1 / 2 / 2 0 1 3 3 : 2 5 : 4 8 P M 867 Appendix 4 List of RIDDOR reportable diseases Occupational diseases Conditions due to physical agents and physical demands of work \200 In \202 ammation, ulceration, or malignant disease of the skin due to ionizing radiation Malignant disease of the bones due to ionizing radiation \200 Blood dyscrasia due to ioni zing radiation. Activity: work with ionizing radiation Cataract due to electromagentic radiation. Activity: work involving exposure to electromagn etic radiation (including radiant heat) Decompression illness \200 Barotrauma resulting in lung or other organ damage \200 Dysb aric osteonecrosis. Activity: work involving breathing gasses at increased pressure (including diving) Cramp of the hand or forearm due to repetitive movements. Activity: work involving prolonge d periods of handwriting, typing or other repetitive movements of the \201 ngers, hand, o r arm Subcutaneous cellulitis of the hand (beat hand). Activity: physically demanding work causing severe or prolonged friction or pressure on the hand Bursitis or subcutaneous cellulitis arising at or about the knee due to severe or prolonged external friction or pressure at or about the knee (beat knee). Acti vity: physically demanding work causing severe or prolonged friction or pressure at or abou t the knee Bursitis or subcutaneous cellulitis arising at or about the elbow due to severe or prolonge d external friction or pressure at or about the elbow (beat elbow). Activity: physically de manding work causing severe or prolonged friction or pressure at or about the elbow Traumatic in \202 ammation of the tendons of the hand or forearm or of the associated tend on sheaths. Activity: physically demanding work, frequent or repeated movements, constraine d postures or extremes of extension or \202 exion of the hand or wrist Carpal tunnel syndrome. Activity : work involving the use of hand-held vibrating tools Hand \200\223arm vibration syndrome. Activity: work involving: the use of chain saws, brush cutters, or hand-held or hand-fed circular saws in forestry or woodworking the use of hand-held rotary tools in grinding material or in sanding or polishing metal the holding of material being ground or metal being sanded or polished by rotary tools 45_Smedley_app04.indd 867 1/2/2013 3:26:37 PM APPENDIX 4 List of RIDDOR reportable diseases 868 the use of hand-held percussive metal working tools or the holding of metal being worked up on by percussive tools in connection with riveting, caulking, chipping, hammering, fettling , or swaging \200 the use of hand-held powered percussive drills or hand-held powered percussive hammers in mining, quarrying, or demolition, or on roads or footpaths (i ncluding road construction) or the holding of material being worked upon by pounding machines in shoe manufacture. Infections due to biological agents \200 Anthrax: activity work involving handling infected animals, their products, or packaging containing infected material or work on infected sites Brucellosis: a ctivity \200\224work involving contact with animals or their carcasses (including any parts thereof) infected by Brucella or the untreated products of same or laboratory specimens or vaccines of or containing Brucella Chlamydiosis: Avian chlamydiosis \200\224activity: work involving contact with birds infected with Chlamy dia psittaci , or the remains or untreated products of such birds Ovine chlamydiosis \200\224activity: work involving contact with sheep infected with chlamy dia psittaci or the remains or untreated products of such sheep Hepatitis: activity \200\224 work involving contact with \200 human blood or human blood products or \200 any source of viral hepatitis Legionellosis: activity \200\224 work on or near cooling systems which are located in the workplace and use water; or work on hot water service systems located in the workplace which are likely to be a source of contamination Leptospirosis : activity \200\224 work in places which are or are liable to be infested by rats, \201 eld mice, voles, or other small mammals work at dog kennels or involving the care or handling of dogs; or \200 work involving con tact with bovine animals or their meat products or pigs or their meat product- s Lyme disease : activity \200\224work involving exposure to ticks (including in particular w ork by forestry workers, rangers, dairy farmers, gamekeepers, and other persons engaged in countryside management) \200 Q fever : activity \200\224work involving contact with anima ls, their remains, or their untreated products Rabies : activity \200\224work involving handling or contact with infected animals Streptococcus suis : activity \200\224work involving contact with pigs infected with Streptococcus suis, or with the carcasses, products, or residues of pigs so affected Tetanus: activity \200\224 work involving contact with soil likely to be contaminated by animals 45_Smedley_app04.indd 868 1/2/2013 3:26:37 PM LIST OF RIDDOR REPORTABLE DISEASES 869 Tuberculosis: activity \200\224work with persons, animals, human or animal remains, or any other material which might be a source of infection \200 Any infection reliably attributa ble to the performance of the work speci \201 ed in the entry opposite hereto. Activity: w ork with micro- organisms; work with live or dead human beings in the course of providing a ny treatment or service or in conducting any investigation involving exposure to blood or b ody \202 uids; work with animals or any potentially infected material derived from any of these activities. Conditions due to substances \200 Poisoning by any of the following: acrylamide monomer \200 arsenic or one of its compounds \200 benzene or a homologue of benzene \200 beryllium or one of its compounds \200 cadmium or one of its compounds \200 carbon disulphide \200 diethylene dioxide (dioxan) \200 ethylene oxide \200 lea d or one of its compounds \200 manganese or one of its compounds \200 mercury or one of its compounds \200 methyl bromide \200 nitrochlorobenzene, or a nitro-, amino-, or chl oro-derivative of benzene or of a homologue of benzene oxides of nitrogen \200 phosphorus or one of its compounds Activity: any activity \200 Cancer of a bronchus or lung . Activity : work in or about a building where nickel is produced by decomposition of a gaseous nickel compound or where any industrial process which is ancilla ry or incidental to that process is carried on; or work involving exposure to bis (chloromethyl) ether or any electrolytic chromium processes (excluding passivation) which involve hexavalent chromium c ompounds, chromate production, or zinc chromate pigment manufacture Primary carcinoma of the lung where there is accompanying evidence of silicosis. Activity: any occupation in \200\224 \200 glass manufacture \200 sandston e tunneling or quarrying \200 the pottery industry \200 metal ore mining \200 slate q uarrying or slate production \200 clay mining \200 the use of siliceous materials as ab rasives \200 foundry work \200 granite tunneling or quarrying; or \200 stone cutting or masonry 45_Smedley_app04.indd 869 1/2/2013 3:26:38 PM APPENDIX 4 List of RIDDOR reportable diseases 870 Cancer of the urinary tract . Activity: work involving exposure to any of the following substances \200\224 \200 beta-naphthylamine or methylene-bis-orthochloroani line \200 diphenyl substituted by at least one nitro or primary amino group or by at least one nitro and primary amino group (including benzidine) any of the substances mentioned in the subparagraph above if further ring substituted by halogeno, methyl, or methoxy groups, but not by other groups or the salts of any of the substances mentioned in the subparagraphs above; or the manufacture of auramine or magenta Bladder cancer : activity \200\224work involving exposure to aluminum smelting using the Soderberg process Angiosarcoma of the liver: activity; work in or about machinery or apparatus used for the polymerization of vinyl chloride monomer, a process which, for the purposes of this subpara graph, comprises all operations up to and including the drying of the slurry produced by th e polymerization and the packaging of the dried product or work in a building or structure in which any part of the process referred to in the foregoing subparagraph takes place Peripheral neuropathy : activity \200\224work involving the use of handling of or exposure to the fumes of or vapor containing n-hexane or methyl- n-butyl ketone Chrome ulceration of: the nose or throat or \200 the skin of the hands or forearm Activity: work involving exposure to chromic acid or to any other chro- mium compound. \200 Folliculitis: activity \200\224work involving exposure to mineral oil, tar, pitch, or arsenic Acne: activity \200\224work involving exposure to mineral oil, tar, pitch, or arsenic Skin cancer : activity \200\224work involving exposure to mineral oil, tar, pitch, or arsenic Pneumoconiosis (excluding asbestosis) : activity \200\224 the mining, quarrying or working of silica rock or the working of dried quartzose sand, any dry deposit or residue of silica, or any dry admixture containing such materials (includin g any activity in which any of the aforesaid operations are carried out incidentally to the mining or quarrying of other minerals or to the manufacture of articles containing crushed or ground silica rock) or the handling of any of the materials speci \201 ed in the foregoing sub- paragraph in or i ncidentally to any of the operations mentioned therein or substantial exposure to the dust arising from such operations The breaking, crushing, or grinding of \202 int, the working or handling of broken, crush ed, or ground \202 int or materials containing such 45_Smedley_app04.indd 870 1/2/2013 3:26:38 PM LIST OF RIDDOR REPORTABLE DISEASES 871 \202 int, or substantial exposure to the dust arising from any of such operations Sand blasting by means of compressed air with the use of quartzose sand or crushed silica r ock or \202 int or substantial exposure to the dust arising from such sand blasting Work in a foundry or the performance of, or substantial exposure to, the dust arising from any of the following operations: \200\224 the freeing of steel c astings from adherent siliceous substance or \200\224 the freeing of metal castings from a dherent siliceous substance: \200\224 by blasting with an abrasive propelled by compressed air, steam, or a wheel or \200\224 by the use of power-driven tools The manufacture of china or earthenware (including sanitary earthenware, electrical earthenware, and earthenware tiles) and any activity involving subs tantial exposure to the dust arising therefrom The grinding of mineral graphite or substantial exposure to the dust arising from such grinding The dressing of granite or any igneous rock by masons, the crushing of such materials, or s ubstantial exposure to the dust arising from such operations The use or preparation for use of an abrasive wheel or substantial exposure to the dust arising therefrom Work underground in any mine in which one of the objects of the mining operations is the getting of any material the working or handling above ground at any coal or tin mine of any materials extracted the refrom or any operation incidental thereto \200 the trimming of coal in any ship, barge, lighter, dock, or harbor, or at any wharf or quay or the sawing, splitting, or dressing of slate or any operation incidental thereto The manufacture of work incidental to the manufacture of carbon electrodes by an industrial undertaking for use in the electrolytic extraction of aluminum from aluminum oxide and any activity involving substantial exposure to the dust therefrom Boiler scaling or substantial exposure to the dust arising therefrom \200 Byssinosis : ac tivity \200\224 the spinning or manipulation of raw or waste cotton or \202 ax or the weaving of cotton or \202 ax, carried out in each case in a room in a factory, together with any other work carried out in such a room Mesothelioma \200 Lung cancer \200 Asbestosis: activity \200\224 the working or handling of asbestos or any admixture of asbestos \200 the manufacture or repair of asbestos textiles or other articles containing or composed of asbestos the cleaning of any machinery or plant used in any of the foregoing operations and of any c hambers, \201 xtures, and appliances for the collection of asbestos dust; or substantial exposure to the dust arising from any of the foregoing operations 45_Smedley_app04.indd 871 1/2/2013 3:26:38 PM APPENDIX 4 List of RIDDOR reportable diseases 872 Cancer of the nasal cavity or associated air sinuses : a ctivity \200\224 \200 work in or about a building where wooden furniture is manufactured or work in a building used for the manufacture of footwear or components of footwear made wholly or partly of leather or \201 bre board; or work at a place used wholly or mainly for the repair of footwear made wholly or partly of leather or \201 bre board or work in or about a factory building where nickel is produced by decomposition of a gaseous nickel compound or in any process which is ancillary or incidental thereto Occupational dermatitis : activity \200\224work involving exposure to any of the following agents: \200 epoxy resin systems \200 formaldehyde and its resins \200 metalworking \202 uids \200 chromate (hexavalent and derived from trivalent chromium) \200 cement, plaster, or concrete \200 acrylates and methacrylates \200 colophony (ros in) and its modi \201 ed products \200 glutaraldehyde \200 mercaptobenzothiazole, thiu rams, substituted para-phenylene- diamines and related rubber processing chemicals \200 biocides, antibacterials, preservat ives, or disinfectants \200 organic solvents \200 antibiotics and other pharmaceuticals and therapeutic agents \200 strong acids, strong alkalis, strong solutions (e.g. brine), and oxidizing agents including domestic bleach or reducing agents \200 hairdressing products including in particular dyes, shampoos, bleaches, and permanent waving solutions soaps and detergents \200 plants and plant-derived material including in particular the d affodil, tulip, and chrysanthemum families, the parsley family (carrots, parsnips, parsley, and cele ry), garlic and onion, hardwoods and the pine family \201 sh, shell- \201 sh, or meat \200 sugar or \202 our or \200 any other known ir ritant or sensitizing agent including in particular any chemical bearing the warning \200 \230may cause sensitization by skin contact \200\231 or \200\230irritating to the skin \200\231 Extrinsic alveolitis (including farmer \200\231s lung) : activity \200\224exposure to molds , fungal spores, or heterologous proteins during work in: \200 agriculture, horticulture, forestry, cultivation of edible fungi, or malt-working loading, unloading, or handling moldy vegetable matter or edible fungi whilst the same is being stored caring for or handling birds or \200 handling bagasse 45_Smedley_app04.indd 872 1/2/2013 3:26:38 PM LIST OF RIDDOR REPORTABLE DISEASES 873 Occupational asthma : activity \200\224work involving exposure to any of the following agents: \200 isocyanates \200 platinum salts \200 fumes or dust arising fro m the manufacture, transportation, or use of hardening agents (including epoxy resin curing agents) based on phthalic anhydride, tetr achlorophthalic anhydride, trimellitic anhydride or triethylene-tetramine fumes arising from the use of rosin as a soldering \202 ux \200 proteolytic enzymes \200 animals including insects and other arthropods used for the purposes of research or education or in laboratories dusts arising from the sowing, cultivation, harvesting, drying, handling, milling, transportation, or storage of barley, oats, rye, wheat, or maize or the handling, milling, transportation or storage of meal or \202 our made therefrom antibiotics \200 cimetidine \200 wood dust \200 ispaghula \200 castor bean dust \200 ipecacuanha \200 azodicarbonamide \200 animals including insects and other arthro pods (whether in their larval forms or not) used for the purposes of pest control or fruit cultivation or the larv al forms of animals used for the purposes of research or education or in laboratories glutaraldehyde \200 persulphate salts or henna \200 crustaceans or \201 sh or product s arising from these in the food processing industry reactive dyes \200 soya bean \200 tea dust \200 green coffee bean dust \200 fumes f rom stainless steel welding \200 any other sensitizing agent, including in particular any chemical bearing the warning \200\230may cause sensitization by inhalation \200\231. Appendix 4 is reproduced with permission from HSE. 45_Smedley_app04.indd 873 1/2/2013 3:26:38 PM This page intentionally left blank 875 Appendix 5 Informatics in occupational health The use of information technology in occupational medicine is continu- ally increasing. A g reat deal of practical information is available on the worldwide web. Wherever possible, us eful websites and web refer- ences for guidance documents have been quoted within speci \201 c topics throughout this handbook. Listed here are websites that are useful for OH pra ctice. UK professional bodies in OH \200 Faculty of Occupational Medicine (FOM). Available at: M www.fom.ac.uk Society of Occupational Medicine (SOM). Available at: M http://www.som.org.uk/ British Occupational Hygiene Society (BOHS). Available at: M http://www.bohs.org Institution of Occupational Safety and Health (IOSH). Available at: M http://www.iosh.co.uk Specialist /industry-speci \201 c practitioner groups Some require a membership subscripti on, but selected material is free. \200 Association of NHS Occupational Physicians (ANHOP S). Available at: M http://www.anhops.com/ Association of Local Authority Medical Advisers (ALAMA). Available at: M http://www.alama.org.uk/ Commercial Occupational Health Providers Association (COHPA). Available at: M http://www.cohpa.co.uk/ Discussion forum Occenvmed. Available at: M http://www.occmed.free-online.co.uk/page5. html Academic departments of occupational medicine \200 The Institute of Occupational and Envi ronmental Medicine, University of Birmingham. Available at: M http://www.birmingham.ac.uk/schools/haps/ departments/ioem/i ndex.aspx Center for Occupational and Environmental Health, University of Manchester. Available at: M http://www.medicine.manchester.ac.uk/oeh/ Medical Research Council Epidemiology Resource Center, University of Southampton. Available at: M http://www.mrc.soton.ac.uk/index.asp?page=33 46_Smedley_app05.indd 875 1/2/2013 3:29:44 PM APPENDIX 5 Informatics in occupational health 876 Department of Occupational and Environmental Medicine, National Heart and Lung Institute. Available at: M http://www.lungsatwork.org.uk/clinical.php Other university departments of occupational and environmental medicine can be located through the respective university websites. Occupational and environmental medicine journals \200 Occupational and Environmental Medi cine . Available at: M http://oem.bmjjournals.com/ Occupational Medicine . Available at: M http://occmed.oxfordjournals.org/ \200 Scandinavian Journal of Work, Envi ronment and Health . Available at: M http://www.sjweh. \201 / Journal of Occupational and Environmental Medicine . Available at: M http://www.joem.org/pt/re/joem/home Annals of Occupational Hygiene . Available at: M http://annhyg.oxfordjournals.org/ Links to other occupational health disciplines \200 British Thoracic Society. Available at: M http://www.brit-thoracic.org.uk/ Ergonomics Society. Available at: M http://www.ergonomics.org.uk/ Other useful UK websites \200 Health, Environment and Work (HEW). Available at: M http://www.agius.com/hew/index.htm UK Health and Safety Executive (HSE). Available at: M http://www.hse.gov.uk HSE statistics. Available at: M http://www.hse.gov.uk/statistics/ UK Health Protection Agency. Available at: M http://www.hpa.org.uk Clinical evidence. Available at: M http://www.clinicalevidence.com/ceweb/conditions/ index.jsp National Institute for Health and Clinical Excellence (NICE). Available at: M http://www.nice.org.uk/ NHS Plus. Available at: M http://www.nhsplus.nhs.uk/ UK Department for Work and Pensions. Available at: M http://www.dwp.gov.uk/ International websites \200 European Agency for Safety and Health at Work. Available at: M http://europe.osha.eu.int/OSHA National Institute for Occupational Health and Safety (USA). Available at: M http://www.cdc .gov/niosh/homepage.html World Health Organization (WHO). Available at: M http://www.who.int/en/ \200 International Research on Cancer (IARC). Available at: M http://www.iarc.fr/ 46_Smedley_app05.indd 876 1/2/2013 3:29:44 PM 877 Appendix 6 Lung volumes 47_Smedley_app06.indd 877 1/2/2013 3:30:59 PM APPENDIX 6 Lung volumes 878 IC FEV1 VC TLC FRC Fig. A6.1 Subdivisions of lung volume illustrated by spirometric recording of volume agains t time during tidal breathing for three breaths, followed by maximal inspiration and then m aximal forced expiration, before returning to tidal breathing in a normal subject. RV, resi dual volume; FRC, functional residual capacity; IC, inspiratory capacity; TLC, total lung c apacity; FEV1, forced expiratory volume in 1 s; VC, vital capacity; VT, tidal volume. Note that TLC = FRC + IC = VC + RV. Reproduced with permission from the Warrell DA, et al (2003) . Oxford Textbook of Medicine , 4 edn, vol. 2. By permission of Oxford University Press. 47_Smedley_app06.indd 878 1/2/2013 3:30:59 PM 879 Appendix 7 Height and weight converter and body mass index (BMI) calculator 48_Smedley_app07.indd 879 1/2/2013 3:32:05 PM APPENDIX 7 Height and weight converter 880 BMI calculator Height in meters 6 3 1 0 4 1 4 4 1 8 4 1 2 5 1 6 5 1 0 6 1 4 6 1 8 6 1 2 7 1 6 7 1 0 8 1 4 8 1 8 8 1 2 9 1 6 9 1 0 0 2 . . . . . . . . . . . . . . . . . 125 123 121 119 117 115 113 111 109 107 105 103 101 99 97 95 93 91 89 87 85 83 81 79 77 75 73 71 69 67 65 63 61 59 57 55 53 51 49 47 45 43 64 63 62 61 60 59 58 57 56 55 54 53 52 51 49 48 47 46 45 44 43 42 41 40 39 38 37 36 35 34 3 3 32 31 30 29 28 27 26 25 24 23 22 60 59 58 57 56 55 54 54 53 52 51 50 49 48 47 46 45 44 43 42 41 40 39 38 37 36 35 34 33 32 3 1 30 29 28 27 27 26 25 24 23 22 21 57 56 55 54 53 53 52 51 50 49 48 47 46 45 44 43 42 42 41 40 39 38 37 36 35 34 33 32 32 31 3 0 29 28 27 26 25 24 23 22 21 21 20 54 53 52 52 51 50 49 48 47 46 45 45 44 43 42 41 40 39 39 38 37 36 35 34 33 32 32 31 30 29 2 8 27 26 26 25 24 23 22 21 20 19 19 51 51 50 49 48 47 46 46 45 44 43 42 42 41 40 39 38 37 37 36 35 34 33 32 32 31 30 29 28 28 2 7 26 25 24 23 23 22 21 20 19 18 18 49 48 47 46 46 45 44 43 43 42 41 40 39 39 38 37 36 36 35 34 33 32 32 31 30 29 29 28 27 26 2 5 25 24 23 22 21 21 20 19 18 18 17 46 46 45 44 44 43 42 41 41 40 39 38 38 37 36 35 35 34 33 32 32 31 30 29 29 28 27 26 26 25 2 4 23 23 22 21 20 20 19 18 17 17 16 44 44 43 42 41 41 40 39 39 38 37 36 36 35 34 34 33 32 32 31 30 29 29 28 27 27 26 25 24 24 2 3 22 22 21 20 19 19 18 17 17 16 15 42 42 41 40 40 39 38 38 37 36 35 35 34 33 33 32 31 31 30 29 29 28 27 27 26 25 25 24 23 23 2 2 21 21 20 19 19 18 17 17 16 15 15 40 40 39 38 38 37 36 36 35 35 34 33 33 32 31 31 30 29 29 28 27 27 26 26 25 24 24 23 22 22 2 1 20 20 19 18 18 17 16 16 15 15 14 39 38 37 37 36 35 35 34 34 33 32 32 31 31 30 29 29 28 27 27 26 26 25 24 24 23 23 22 21 21 2 0 19 19 18 18 17 16 16 15 15 14 13 37 36 36 35 35 34 33 33 32 32 31 30 30 29 28 28 27 27 26 26 25 25 24 23 23 22 22 21 20 20 1 9 19 18 17 17 16 16 15 14 14 13 13 35 35 34 34 33 33 32 31 31 30 30 29 29 28 27 27 26 26 25 25 24 23 23 22 22 21 21 20 20 19 1 8 18 17 17 16 16 15 14 14 13 13 12 34 33 33 32 32 31 31 30 30 29 28 28 27 27 26 26 25 25 24 24 23 23 22 21 21 20 20 19 19 18 1 8 17 17 16 15 15 14 14 13 13 12 12 33 32 31 31 30 30 29 29 28 28 27 27 26 26 25 25 24 24 23 23 22 22 21 21 20 20 19 18 18 17 1 7 16 16 15 15 14 14 13 13 12 12 11 31 31 30 30 29 29 28 28 27 27 26 26 25 25 24 24 23 23 22 22 21 21 20 20 19 19 18 18 17 17 1 6 16 15 15 14 14 13 13 12 12 11 11 68 67 65 64 63 62 61 60 59 58 57 56 55 54 52 51 50 49 48 47 46 45 44 43 42 41 39 38 37 36 3 5 34 33 32 31 30 29 28 26 25 24 23 s m a r g o l i k n i t h g e i W BMI <18.5 \200\223 underweight BMI 30 \200\22339.9 \200\223 obese BMI 18.5 \200\22324.9 \200\223 acceptable weight BMI >= 40 \200\223 morbid obesity BMI 25 \200\22329.9 \200\223 overweight BMI calculator Fig A7.1 BMI calculator. 48_Smedley_app07.indd 880 1/2/2013 3:32:05 PM HEIGHT AND WEIGHT CONVERTER 881 Height converter Table A7.1 Height converter Height (ft and in) Height (m) 5 \200\2310 \200\235 1.52 5 \200\2311 \200\235 1.55 5 \200\2312 \200\235 1.58 5 \200\2313 \200\235 1.60 5 \200\2314 \200\235 1.63 5 \200\2315 \200\235 1.65 5 \200\2316 \200\235 1.68 5 \200\2317 \200\235 1.70 5 \200\2318 \200\235 1.73 5 \200\2319 \200\235 1.75 5 \200\23110 \200\235 1.78 5 \200\23111 \200\235 1.80 6 \200\2310 \200\235 1.83 6 \200\2311 \200\235 1.85 6 \200\2312 \200\235 1.88 6 \200\2313 \200\235 1.90 6 \200\2314 \200\235 1.93 6 \200\2315 \200\235 1.96 6 \200\2316 \200\235 1.98 48_Smedley_app07.indd 881 1/2/2013 3:32:06 PM APPENDIX 7 Height and weight converter 882 Weight conversion chart Table A7.2 Weight conversion chart kg lbs St/ pounds kg lbs St/ pounds kg lbs St/ pounds 38.1 84 6 0 54.0 119 8 7 69.9 154 11 0 38.6 85 6 1 54.4 120 8 8 70.3 155 11 1 39.0 86 6 2 54.9 121 8 9 70.8 156 11 2 39.5 87 6 3 55.3 122 8 10 71.2 157 11 3 39.9 88 6 4 55.8 123 8 11 71.7 158 11 4 40.4 89 6 5 56.2 124 8 12 72.1 159 11 5 40.8 90 6 6 56.7 125 8 13 72.6 160 11 6 41.3 91 6 7 57.2 126 9 0 73.0 161 11 7 41.7 92 6 8 57.6 127 9 1 73.5 162 11 8 42.2 93 6 9 58.1 128 9 2 73.9 163 11 9 42.6 94 6 10 58.5 129 9 3 74.4 164 11 10 43.1 95 6 11 59.0 130 9 4 74.8 165 11 11 43.5 96 6 12 59.4 131 9 5 75.3 166 11 12 44.0 97 6 13 59.9 132 9 6 75.7 167 11 13 44.5 98 7 0 60.3 133 9 7 76.2 168 12 0 44.9 99 7 1 60.8 134 9 8 76.7 169 12 1 45.4 100 7 2 61.2 135 9 9 77.1 170 12 2 45.8 101 7 3 61.7 136 9 10 77.6 171 12 3 46.3 102 7 4 62.1 137 9 11 78.0 172 12 4 46.7 103 7 5 62.6 138 9 12 78.5 173 12 5 47.2 104 7 6 63.0 139 9 13 78.9 174 12 6 47.6 105 7 7 63.5 140 10 0 79.4 175 12 7 48.1 106 7 8 64.0 141 10 1 79.8 176 12 8 48.5 107 7 9 64.4 142 10 2 80.3 177 12 9 49.0 108 7 10 64.9 143 10 3 80.7 178 12 10 49.4 109 7 11 65.3 144 10 4 81.2 179 12 11 49.9 110 7 12 65.8 145 10 5 81.6 180 12 12 50.3 111 7 13 66.2 146 10 6 82.1 181 12 13 50.8 112 8 0 66.7 147 10 7 82.6 182 13 0 51.3 113 8 1 67.1 148 10 8 83.0 183 13 1 51.7 114 8 2 67.6 149 10 9 83.5 184 13 2 52.2 115 8 3 68.0 150 10 10 83.9 185 13 3 52.6 116 8 4 68.5 151 10 11 84.4 186 13 4 53.1 117 8 5 68.9 152 10 12 84.8 187 13 5 53.5 118 8 6 69.4 153 10 13 85.3 188 13 6 48_Smedley_app07.indd 882 1/2/2013 3:32:06 PM HEIGHT AND WEIGHT CONVERTER 883 Table A7.2 (Cont \200\231d) kg lbs St/ pounds kg lbs St/ pounds kg lbs St/ pounds 85.7 189 13 7 99.8 220 15 10 113.9 251 17 13 86.2 190 13 8 100.2 221 15 11 114.3 252 18 0 86.6 191 13 9 100.7 222 15 12 114.8 253 18 1 87.1 192 13 10 101.2 223 15 13 115.2 254 18 2 87.5 193 13 11 101.6 224 16 0 115.7 255 18 3 88.0 194 13 12 102.1 225 16 1 116.1 256 18 4 88.4 195 13 13 102.5 226 16 2 116.6 257 18 5 88.9 196 14 0 103.0 227 16 3 117.0 258 18 6 89.4 197 14 1 103.4 228 16 4 117.5 259 18 7 89.8 198 14 2 103.9 229 16 5 117.9 260 18 8 90.3 199 14 3 104.3 230 16 6 118.4 261 18 9 90.7 200 14 4 104.8 231 16 7 118.8 262 18 10 91.2 201 14 5 105.2 232 16 8 119.3 263 18 11 91.6 202 14 6 105.7 233 16 9 119.7 264 18 12 92.1 203 14 7 106.1 234 16 10 120.2 265 18 13 92.5 204 14 8 106.6 235 16 11 120.7 266 19 0 93.0 205 14 9 107.0 236 16 12 121.1 267 19 1 93.4 206 14 10 107.5 237 16 13 121.6 268 19 2 93.9 207 14 11 108.0 238 17 0 122.0 269 19 3 94.3 208 14 12 108.4 239 17 1 122.5 270 19 4 94.8 209 14 13 108.9 240 17 2 122.9 271 19 5 95.3 210 15 0 109.3 241 17 3 123.4 272 19 6 95.7 211 15 1 109.8 242 17 4 123.8 273 19 7 96.2 212 15 2 110.2 243 17 5 124.3 274 19 8 96.6 213 15 3 110.7 244 17 6 124.7 275 19 9 97.1 214 15 4 111.1 245 17 7 125.2 276 19 10 97.5 215 15 5 111.6 246 17 8 125.6 277 19 11 98.0 216 15 6 112.0 247 17 9 126.1 278 19 12 98.4 217 15 7 112.5 248 17 10 126.6 279 19 13 98.9 218 15 8 112.9 249 17 11 127.0 280 20 0 99.3 219 15 9 113.4 250 17 12 127.5 281 20 1 Reproduced with kind permission of Dr D.B. Shackleton MRCP MFOM. Available at: M www. ocche alth.co.uk/WeightConversion.htm 48_Smedley_app07.indd 883 1/2/2013 3:32:07 PM This page intentionally left blank 885 Appendix 8 Agents classi \201 ed by the IARC monographs, volumes 1 \200\223106 CAS No. Agent Group Volume Year 1 100E 2012 000075 \200\22307 \200\2230 Acetaldehyde associated with consumption of alcoholic beverages 1 54, 100F 2012 Acid mists, strong inorganic 001402 \200\22368 \200\2232 A \202 atoxins 1 56, 82, 100F 2012 Alcoholic beverages 1 44, 96, 100E 2012 Aluminum production 1 34, Sup 7, 100F 2012 000092 \200\22367 \200\2231 4 Aminobiphenyl 1 1, Sup 7, 99, 100F 2012 Areca nut 1 85, 100E 2012 000313 \200\22367 \200\2237 Aristolochic acid (NB: Overall evaluation upgraded to Group 1 based on mechanistic and othe r relevant data) 1 82, 100A 2012 000313 \200\22367 \200\2237 Aristolochic acid, plants containing 1 82, 100A 2012 007440 \200\22338 \200\2232 Arsenic and inorganic arsenic compounds 1 23, Sup 7, 100C 2012 001332 \200\22321 \200\2234 013768 \200\22300 \200\2238 012172 \200\22373 \200\2235 017068 \200\22378 \200\2239 012001 \200\22329 \200\2235 012001 \200\22328 \200\2234 014567 \200 \22373 \200\2238 Asbestos (all forms, including actinolite, amosite, anthophyllite, chrysotile, crocidolite, tremolite) (NB: Mineral substances (e.g. talc or vermiculite) that contain asbestos should also be regarded as carcinogenic to humans.) 1 14, Sup 7, 100C 2012 Auramine production 1 Sup 7, 99, 100F 2012 000446 \200\22386 \200\2236 Azathioprine 1 26, Sup 7, 100A 2012 000071 \200\22343 \200\2232 Benzene 1 29, Sup 7. 100F 2012 000092 \200\22387 \200\2235 Benzidine 1 29, Sup 7, 99, 100F 2012 Benzidine, dyes metabolized to (NB: Overall evaluation upgraded to Group 1 based on mechani stic and other relevant data) 1 99, 100F 2012 49_Smedley_app08.indd 885 1/2/2013 3:32:53 PM APPENDIX 8 Agents Classi \201 ed by the IARC Monographs 886 CAS No. Agent Group Volume Year 1 92, 100F 2012 000050 \200\22332 \200\2238 Benzo[a]pyrene (NB: Overall evaluation upgraded to Group 1 based on mechanistic and other r elevant data) 007440 \200\22341 \200\2237 Beryllium and beryllium compounds 1 58, 100C 2012 Betel quid with tobacco 1 85, 100E 2012 Betel quid without tobacco 1 85, 100E 2012 000542 \200\22388 \200\2231 000107 \200\22330 \200\2232 Bis(chloromethyl)ether; chloromethyl methyl ether (technical-grade) 1 4, Sup 7, 100F 2012 000055 \200\22398 \200\2231 Busulfan 1 4, Sup 7, 100A 2012 000106 \200\22399 \200\2230 1,3 Butadiene 1 97, 100F 2012 007440 \200\22343 \200\2239 Cadmium and cadmium compounds 1 58, 100C 2012 000305 \200\22303 \200\2233 Chlorambucil 1 26, Sup 7, 100A 2012 000494 \200\22303 \200\2231 Chlornaphazine 1 4, Sup 7, 100A 2012 018540 \200\22329 \200\2239 Chromium (VI) compounds 1 49, 100C 2012 Clonorchis sinensis (infection with) 1 61, 100B 2012 Coal, indoor emissions from household combustion of 1 95, 100E 2012 Coal gasi \201 cation 1 92, 100F 2012 008007 \200\22345 \200\2232 Coal-tar distillation 1 92, 100F 2012 065996 \200\22393 \200\2232 Coal-tar pitch 1 35, Sup 7, 100F 2012 Coke production 1 92, 100F 2012 000050 \200\22318 \200\2230 006055 \200\22319 \200\2232 Cyclophosphamide 1 26, Sup 7, 100A 2012 059865 \200\22313 \200\2233 Cyclosporine 1 50, 100A 2012 079217 \200\22360 \200\2230 000056 \200\22353 \200\2231 Diethylstilbestrol 1 21, Sup 7, 100A 2012 Engine exhaust, diesel 1 46, 105 in prep Epstein-Barr virus 1 70, 100B 2012 066733 \200\22321 \200\2239 Erionite 1 42, Sup 7, 100C 2012 49_Smedley_app08.indd 886 1/2/2013 3:32:53 PM AGENTS CLASSIFIED BY THE IARC MONOGRAPHS 887 CAS No. Agent Group Volume Year Estrogen therapy, postmenopausal 1 72, 100A 2012 Estrogen-progestogen menopausal therapy (combined) 1 72, 91, 100A 2012 Estrogen-progestogen oral contraceptives (combined) (NB: There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium an d ovary) 1 72, 91, 100A 2012 000064 \200\22317 \200\2235 Ethanol in alcoholic beverages 1 96, 100E 2012 000075 \200\22321 \200\2238 Ethylene oxide (NB: Overall evaluation upgraded to Group 1 based on mechanistic and other r elevant data) 1 97, 100F 2012 033419 \200\22342 \200\2230 Etoposide (NB: Overall evaluation upgraded to Group 1 based on mechanistic and other releva nt data) 1 76, 100A 2012 033419 \200\22342 \200\2230 015663 \200\22327 \200\2231 011056 \200\22306 \200\2237 Etoposide in combination with cisplatin and bleomycin 1 76, 100A 2012 Fission products, including strontium-90 1 100D 2012 000050 \200\22300 \200\2230 Formaldehyde 1 88, 100F 2012 Haematite mining (underground) 1 1, Sup 7, 100D 2012 Helicobacter pylori (infection with) 1 61, 100B 2012 Hepatitis B virus (chronic infection with) 1 59, 100B 2012 Hepatitis C virus (chronic infection with) 1 59, 100B 2012 Human immunode \201 ciency virus type 1 (infection with) 1 67, 100B 2012 Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 (NB: The HPV type s that have been classi \201 ed as carcinogenic to humans can differ by an order of magnit ude in risk for cervical cancer) 1 64, 90, 100B 2012 49_Smedley_app08.indd 887 1/2/2013 3:32:53 PM APPENDIX 8 Agents Classi \201 ed by the IARC Monographs 888 CAS No. Agent Group Volume Year Human T-cell lymphotropic virus type I 1 67, 100B 2012 Ionizing radiation (all types) 1 100D 2012 Iron and steel founding (occupational exposure during) 1 34, Sup 7, 100F 2012 Isopropyl alcohol manufacture using strong acids 1 Sup 7, 100F 2012 Kaposi sarcoma herpesvirus 1 70, 100B 2012 Leather dust 1 100C 2012 Magenta production 1 57, 99, 100F 2012 000148 \200\22382 \200\2233 Melphalan 1 9, Sup 7, 100A 2012 000298 \200\22381 \200\2237 Methoxsalen 1 24, Sup 7, 100A 2012 (8-methoxypsoralen) plus ultraviolet A radiation 000101 \200\22314 \200\2234 4,4 \200\231 Methylenebis (2-chloroaniline) (MOCA) (NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data) 1 57, 99, 100F 2012 Mineral oils, untreated or mildly treated 1 33, Sup 7, 100F 2012 MOPP and other combined chemotherapy including alkylating agents 1 Sup 7, 100A 2012 000091 \200\22359 \200\2238 2 Naphthylamine 1 4, Sup 7, 99, 100F 2012 Neutron radiation (NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data) 1 75, 100D 2012 Nickel compounds 1 49, 100C 2012 016543 \200\22355 \200\2238 N \200\231-Nitrosonornicotine (NNN) and 4-(N- 1 89, 100E 2012 064091 \200\22391 \200\2234 Nitrosomethylamino)-1- (3-pyridyl)-1-butanone (NNK) (NB: Overall evaluation upgraded to Group 1 based on mechanist ic and other relevant data) Opisthorchis viverrini (infection with) 1 61, 100B 2012 Painter (occupational exposure as a) 1 47, 98, 100F 2012 49_Smedley_app08.indd 888 1/2/2013 3:32:53 PM AGENTS CLASSIFIED BY THE IARC MONOGRAPHS 889 CAS No. Agent Group Volume Year 1 100F 2012 057465 \200\22328 \200\2238 3,4,5,3 \200\231,4 \200\231 Pentachlorobiphenyl (PCB-126) (NB: Overall evaluation upgraded to Group 1 based on mechanis tic and other relevant data) 057117 \200\22331 \200\2234 2,3,4,7,8 Pentachlorodibenzofuran (NB: Overall evaluation upgraded to Group 1 based on mechanistic an d other relevant data) 1 100F 2012 000062 \200\22344 \200\2232 Phenacetin (NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data) 1 24, Sup 7, 100A 2012 Phenacetin, analgesic mixtures containing 1 Sup 7, 100A 2012 014596 \200\22337 \200\2233 Phosphorus-32, as phosphate 1 78, 100D 2012 007440 \200\22307 \200\2235 Plutonium 1 78, 100D 2012 Radioiodines, including iodine-131 1 78, 100D 2012 Radionuclides, alpha-particle-emitting, internally deposited (NB: Speci \201 c radionuclid es for which there is suf \201 cient evidence in humans are also listed individually as Gr oup 1 agents) 1 78, 100D 2012 Radionuclides, beta-particle-emitting, internally deposited (NB: Speci \201 c radionuclide s for which there is suf \201 cient evidence in humans are also listed individually as Gro up 1 agents) 1 78, 100D 2012 013233 \200\22332 \200\2234 Radium-224 and its decay products 1 78, 100D 2012 013982 \200\22363 \200\2233 Radium-226 and its decay products 1 78, 100D 2012 015262 \200\22320 \200\2231 Radium-228 and its decay products 1 78, 100D 2012 010043 \200\22392 \200\2232 Radon-222 and its decay products 1 43, 78, 100D 2012 Rubber manufacturing industry 1 28, Sup 7, 100F 2012 Salted \201 sh, Chinese-style 1 56, 100E 2012 49_Smedley_app08.indd 889 1/2/2013 3:32:53 PM APPENDIX 8 Agents Classi \201 ed by the IARC Monographs 890 CAS No. Agent Group Volume Year Schistosoma haematobium (infection with) 1 61, 100B 2012 013909 \200\22309 \200\2236 Semustine [1-(2-Chloroethyl)-3- (4-methylcyclohexyl)-1-nitrosou rea, Methyl-CCNU] 1 Sup 7, 100A 2012 068308 \200\22334 \200\2239 Shale oils 1 35, Sup 7, 100F 2012 014808 \200\22360 \200\2237 Silica dust, crystalline, in the form of quartz or cristobalite 1 68, 100C 2012 Solar radiation 1 55, 100D 2012 Soot (as found in occupational exposure of chimney sweeps) 1 35, Sup 7, 100F 2012 000505 \200\22360 \200\2232 Sulfur mustard 1 9, Sup 7, 100F 2012 010540 \200\22329 \200\2231 Tamoxifen (NB: There is also conclusive evidence that tamoxifen reduces the risk of contral ateral breast cancer in breast cancer patients) 1 66, 100A 2012 001746 \200\22301 \200\2236 2,3,7,8 Tetrachlorodibenzo-para-dioxin 1 69, 100F 2012 000052 \200\22324 \200\2234 Thiotepa 1 50, 100A 2012 007440 \200\22329 \200\2231 Thorium-232 and its decay products 1 78, 100D 2012 Tobacco, smokeless 1 89, 100E 2012 Tobacco smoke, second-hand 1 83, 100E 2012 Tobacco smoking 1 83, 100E 2012 000095 \200\22353 \200\2234 ortho-Toluidine 1 77, 99, 100F 2012 000299 \200\22375 \200\2232 Treosulfan 1 26, Sup 7, 100A 2012 000079 \200\22301 \200\2236 Trichloroethylene 1